ID   2G12-2B2
AC   CVCL_E5NR
RX   Patent=US9879087;
RX   Patent=US11401330;
RX   PubMed=28281872;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_61818; N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine (CD175s; Sialyl-Tn) (Note=O-linked to serine or threonine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=28281872; DOI=10.1080/19420862.2017.1290752; PMCID=PMC5419082;
RA   Prendergast, Jillian M.
RA   Galvao da Silva, Ana Paula
RA   Eavarone, David A.
RA   Ghaderi, Darius
RA   Zhang, Mai
RA   Brady, Dane
RA   Wicks, Joan
RA   DeSander, Julie
RA   Behrens, Jeffrey
RA   Rueda, Bo R.
RT   "Novel anti-sialyl-Tn monoclonal antibodies and antibody-drug
RT   conjugates demonstrate tumor specificity and anti-tumor activity.";
RL   MAbs 9:615-627(2017).
//
RX   Patent=US9879087;
RA   DeSander, Julie
RA   Behrens, Jeffrey
RA   Lugovskoy, Alexey Alexandrovich
RT   "Glycan-interacting compounds and methods of use.";
RL   Patent number US9879087, 30-Jan-2018.
//
RX   Patent=US11401330;
RA   Eavarone, David A.
RA   Behrens, Jeffrey
RA   Lugovskoy, Alexey Alexandrovich
RT   "Glycan-interacting compounds and methods of use.";
RL   Patent number US11401330, 02-Aug-2022.
//